Legislation roundup: Credit cards, pharma R&D and NEEQ listings

| BY

Katherine Jo &clp articles

China is slowly opening up the foreign credit card market, certain R&D reps have been permitted to market drugs and transparency of the New Third Board has been increased

Banking

 

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]